Publication
SEQUENTIAL INTRAVESICAL GEMCITABINE-DOCETAXEL AFTER BCG FAILURE NON-MUSCLE INVASIVE BLADDER CANCER: ONCOLOGICAL OUTCOMES AND SAFETY PROFILE.
Albane Massiet du Biest, Evanguelos Xylinas, Pierre-Etienne Gabriel
The French journal of urologySep 28, 2026PMID 42805394doi:10.1016/j.fjurol.2026.103229 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
INTRODUCTION: Sequential intravesical instillation of gemcitabine and docetaxel (Gem/Doce) has emerging evidence as a bladder-sparing approach in BCG failure non-muscle-invasive bladder cancer (NMIBC). This study aimed to provide additional real-world data by reporting the oncological outcomes and…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Bladder Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.